Vial Announces $67M Series B Led by General Catalyst
Read Vial's feature in the WSJ

Vial at the ASRS 2022 Annual Meeting: Photo Recap

The Vial team attended the American Society of Retina Specialists’ Annual Meeting from July 13-17 in New York, NY. The Vial team that attended included Simon Burns (Co-Founder and CEO), Andrew Brackin (Co-Founder and CRO), Jason Shuris (Head of Sales), Duke Moran (Senior Strategic Growth Executive), and John Sheperdson (Strategic Growth Executive). ASRS 2022 was a huge success, and we’re looking forward to attending again in 2023. To keep up with all of the events that you can meet the Vial team at, follow us on LinkedIn. To learn more about the Vial Ophthalmology CRO, visit our website.

Photography credit: Kinjo S

Contact Us

Note: If you are looking to participate in a clinical trial, please click here
By submitting, you are agreeing to our terms and privacy policy
This field is for validation purposes and should be left unchanged.